InsidersTradesSigma
GD
Gentian Diagnostics ASA Stock: price and management transactions · Norway · Oslo Børs
Follow the Gentian Diagnostics ASA stock price and the full management transaction log of the company, a listed equity based in Norway. Shares are quoted on NO NO, under the oversight of Oslo Børs. Operating in the Health Care sector, Gentian Diagnostics ASA has recorded 23 insider filings. Market capitalisation: €598.2m. The latest transaction was reported on 29 May 2026 (Other). Among the most active insiders: Matti Heinonen. The full history is free.
23
Insider Decl.
0
Thresholds
€703,164
6 ops.
Buy Volume
€5m
2 ops.
Sell Volume
18Σ signal
Fundamental score
Ranked 12,652 of 25,956 companies
52.7
score / 100
Value47
Quality58
FCF yld5.4%
Earn yld2.3%
EV/EBITDA17.2x
ROE-7.6%
Gross mgn56%
Net mgn7.5%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 May 2026
Declarations23 total
5,000 shares@ NOK 35.850.0019% mcap33.9% of flowOptionXOSLOSLO:674916
@ €2.9147OptionXOSLOSLO:668095
3,115 shares@ NOK 40.00100.0% of flowOptionXOSLOSLO:666196
2,500 shares@ NOK 40.0018.0% of flowOptionXOSLOSLO:665812
3,000 shares@ NOK 40.00100.0% of flowOptionXOSLOSLO:665709
5,000 shares@ NOK 54.8672.8% of flowOptionXOSLOSLO:658078
101,848 shares@ NOK 51.50100.0% of flowShareXOSLOSLO:645715
5,000 shares@ NOK 46.200.3% of flowShareXOSLOSLO:643162
1,228,502 shares@ NOK 46.5066.5% of flowShareXOSLOSLO:640237
614,251 shares@ NOK 46.5033.2% of flowShareXOSLOSLO:640236
@ €5.3446OptionXOSLOSLO:634851
180,000 shares@ NOK 38.0705100.0% of flowShareXOSLOSLO:617577
Ideal exit: 26 Jan 2025 (T+270)
OptionXOSLOSLO:604901
5,000 sharesOptionXOSLOSLO:598195
13,800 shares@ NOK 47.50100.0% of flowShareXOSLOSLO:589733
OptionXOSLOSLO:578263
20,000 shares@ NOK 43.5072.5% of flowShareXOSLOSLO:569996
Ideal exit: 26 May 2023 (T+270)
2,166 shares@ NOK 44.538.1% of flowShareXOSLOSLO:569842
Ideal exit: 23 May 2023 (T+270)
800 shares@ NOK 43.002.9% of flowShareXOSLOSLO:569751
Ideal exit: 22 May 2023 (T+270)
3,636 shares@ NOK 55.9416.5% of flowShareXOSLOSLO:555151
Ideal exit: 25 Nov 2022 (T+270)
OptionXOSLOSLO:548211
100,000 shares@ NOK 67.2174100.0% of flowShareXOSLOSLO:540725
23 of 23 declarations
About Gentian Diagnostics ASA
Gentian Diagnostics ASA is a company focused on developing innovative diagnostic tests for medical laboratories. It is listed on the Oslo Stock Exchange.
